AJP - GI Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (September 17, 2009). doi:10.1152/ajpgi.00184.2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/5/G886    most recent
00184.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Xiao, Z. L.
Right arrow Articles by Behar, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, Z. L.
Right arrow Articles by Behar, J.
Submitted on May 14, 2009
Revised on August 17, 2009
Accepted on September 1, 2009

Effects of Progesterone on Motility and Prostaglandin Levels in the Distal Guinea Pig Colon

Zuo Liang Xiao1, Piero Biancani2, and Jose Behar2*

1 Rhode Island Hospital
2 Brown University

* To whom correspondence should be addressed. E-mail: jose_behar{at}brown.edu.

BACKGROUND: Progesterone (P4) inhibits the gastrointestinal muscle contraction by downregulating G{alpha}q/11 proteins that mediate contraction, by upregulating G{alpha}s proteins that mediate relaxation and by altering the pattern of COX enzymes and prostaglandins. AIM: To examine whether P4 treatment of guinea pigs in vivo affects basal colon motility (BMI) by altering the levels and actions of PGF2{alpha} and PGE2. METHODS: Guinea pigs were treated with IM progesterone for 4 days. The BMI, the PGF2{alpha} induced contraction and PGE2 induced relaxation were examined in muscle strips and cells. The levels of PGF2{alpha} and PGE2 were measured by radioimmunoassay. RESULTS: Treatment with P4 reduced the BMI, the levels of PGF2{alpha} and PGF2{alpha} induced contraction. P4 increased PGE2 levels and PGE2 induced relaxation. Pretreatment with IM RU-486 (10 mg/kg/day), a P4 receptor antagonist, 1 h prior to P4 blocked the actions of P4. The PGF2{alpha} antagonist Al-1180 abolished BMI and PGF2{alpha} induced contraction. NEM, that block unoccupied membrane receptors, blocked Ach and VIP actions but had no effect on PGF2{alpha} and PGE2 effects. A COX-1 inhibitor decreased and a COX-2 inhibitor increased PGF2{alpha}levels, GTP{gamma}S increased and GDP{beta}S decreased the levels of PGF2{alpha}. G{alpha}q/11 protein antibodies (Abs) reduced PGF2{alpha} levels and G{alpha}i3 Abs blocked its motor actions. G{alpha}s Abs increased PGF2{alpha}but decreased PGE2 levels. CONCLUSION: P4 decreases BMI by reducing PGF2{alpha} levels caused by downregulation of G{alpha}q/11 and PGF2{alpha} induced contraction was blocked by down regulating G{alpha}i3. P4 also decreased the BMI by increasing PGE2 levels and PGE2 induced relaxation by upregulating G{alpha}s proteins.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.